hydroxyproline has been researched along with tiludronic acid in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 7 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Colson, F; Combe, B; Ethgen, D; Geusens, P; Morlock, G; Reginster, JY | 1 |
| Arlot, ME; Delmas, PD; Meunier, PJ; Nilssen, MH; Pastoureau, P; Vergnaud, P | 1 |
| Devogelaer, JP; Dougados, M; Farrerons, J; Gennari, C; Kruse, HP; Mulder, H; Picot, C; Reginster, JY; Roux, C; Titeux, L | 1 |
| Amor, B; Ethgen, D; Franchimont, P; Picot, C; Reginster, JY; Renier, JC; Sany, J; Treves, R | 1 |
| Deroisy, R; Ethgen, D; Franchimont, P; Lecart, MP; Reginster, JY; Zegels, B | 1 |
| Roux, C | 1 |
| Aguirre, C; de la Piedra, C; Díaz Curiel, M; Díaz Diego, EM; Díaz Martín, MA; López Gavilanes, E; Rapado, A | 1 |
5 trial(s) available for hydroxyproline and tiludronic acid
| Article | Year |
|---|---|
Evaluation of the efficacy and safety of oral tiludronate in Paget's disease of bone. A double-blind, multiple-dosage, placebo-controlled study.
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Alkaline Phosphatase; Creatinine; Diphosphonates; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Hydroxyproline; Male; Middle Aged; Osteitis Deformans; Placebos | 1992 |
Comparative prospective, double-blind, multicenter study of the efficacy of tiludronate and etidronate in the treatment of Paget's disease of bone.
Topics: Adult; Aged; Aged, 80 and over; Alkaline Phosphatase; Diphosphonates; Dose-Response Relationship, Drug; Double-Blind Method; Etidronic Acid; Female; Humans; Hydroxyproline; Male; Middle Aged; Osteitis Deformans; Prospective Studies; Time Factors | 1995 |
Efficacy and tolerability of a new formulation of oral tiludronate (tablet) in the treatment of Paget's disease of bone.
Topics: Aged; Aged, 80 and over; Alkaline Phosphatase; Analysis of Variance; Creatinine; Diphosphonates; Female; Humans; Hydroxyproline; Male; Middle Aged; Osteitis Deformans; Tablets | 1994 |
Paget's disease of bone treated with a five day course of oral tiludronate.
Topics: Administration, Oral; Aged; Aged, 80 and over; Alkaline Phosphatase; Creatinine; Diphosphonates; Dose-Response Relationship, Drug; Female; Follow-Up Studies; Humans; Hydroxyproline; Male; Middle Aged; Osteitis Deformans | 1993 |
The methodology of clinical trials of oral tiludronate in Paget's disease of bone.
Topics: Adult; Aged; Aged, 80 and over; Alkaline Phosphatase; Bone Development; Creatinine; Diphosphonates; Double-Blind Method; Female; Guidelines as Topic; Humans; Hydroxyproline; Longitudinal Studies; Male; Middle Aged; Osteitis Deformans; Pain; Prospective Studies; Radiography | 1995 |
2 other study(ies) available for hydroxyproline and tiludronic acid
| Article | Year |
|---|---|
The anabolic effect of human PTH (1-34) on bone formation is blunted when bone resorption is inhibited by the bisphosphonate tiludronate--is activated resorption a prerequisite for the in vivo effect of PTH on formation in a remodeling system?
Topics: Alkaline Phosphatase; Amino Acids; Analysis of Variance; Animals; Biomechanical Phenomena; Bone Density; Bone Development; Bone Resorption; Diphosphonates; Disease Models, Animal; Female; Humans; Hydroxyproline; Ilium; Injections, Subcutaneous; Osteocalcin; Osteoclasts; Osteoporosis, Postmenopausal; Parathyroid Hormone; Peptide Fragments; Sheep; Teriparatide | 1995 |
Variable efficacy of bone remodeling biochemical markers in the management of patients with Paget's disease of bone treated with tiludronate.
Topics: Administration, Oral; Aged; Alkaline Phosphatase; Biomarkers; Bone Remodeling; Bone Resorption; Collagen; Collagen Type I; Creatinine; Diphosphonates; Female; Humans; Hydroxyproline; Male; Middle Aged; Osteitis Deformans; Osteocalcin; Peptide Fragments; Peptides; Procollagen | 1996 |